bimagrumab semaglutide phase 2

Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial: Did Bimagrumab

Did Bimagrumab Beat Semaglutide for Obesity Treatment?

In the phase 2 bimagrumab-semaglutide trial, participants lost 13.6% of body weight versus 9.8% on semaglutide alone, showing the combination beat semaglutide for obesity treatment. This study enrolled 300 adults with BMI over 30, providing robust data on the efficacy of adding bimagrumab to standard therapy. Medical Disclaimer: